Price
Frequently asked questions
What is Amneal's market capitalization?
What is the Earnings Per Share (EPS) for Amneal?
What are the analyst ratings and target price for Amneal's stock?
What is Amneal's revenue over the trailing twelve months?
What is the EBITDA for Amneal?
What is the free cash flow of Amneal?
What is the 5-year beta of Amneal's stock?
How many employees does Amneal have, and what sector and industry does it belong to?
What is the free float of Amneal's shares?
Financials
Market Cap
$2.85B5Y beta
1.15EPS (TTM)
-$0.684Free Float
129.11MRevenue (TTM)
$2.68BEBITDA (TTM)
$546.00MFree Cashflow (TTM)
$229.23MPricing
Analyst Ratings
The price target is $8.25 and the stock is covered by 4 analysts.
Buy
4
Hold
0
Sell
0
Information
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Generics segment includes a retail and institutional portfolio of over 270 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
7,700
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker